Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
CVCVRx, Inc. logo

CVRx, Inc. (CVRX)

NASDAQ Global Select · Currency in USD
$1.42 ▲ +0.05 (+3.65%)
At close: Oct 23, 4:00 PM ET. Market closed.
$1.41 ▼ -0.01 (-0.70%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$1.37
Open
$1.35
Day's Range
$1.33 – $1.47
52 Week Range
$1.25 – $11.30
Volume
199,815
Avg. Volume
758,734
Market Cap
$37.83M
Beta (5Y Monthly)
0.77
PE Ratio (TTM)
--
EPS (TTM)
-$1.96
Earnings Date
Nov 5, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$4.30

Profile: CVRx, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
223
CEO
Kevin Hykes

CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often referred to as systolic heart failure. The company employs a diverse distribution strategy, leveraging its internal sales force, alongside sales agents and independent distributors, to reach markets across the United States, Germany, the wider European continent, and other global territories.

Earnings

Next report: Thu, Nov 5, 2026
EPS estimate -$0.49 · Revenue est. $13.93M
DateEst.Actual
Aug 6, 2026-$0.52-$0.53Miss
May 11, 2026-$0.51-$0.50Beat
Feb 12, 2026-$0.42-$0.46Miss
Nov 5, 2025-$0.50-$0.49Beat
Aug 4, 2025-$0.52-$0.57Miss
May 8, 2025-$0.56-$0.53Beat

Analyst view

Consensus price target
$4.30 ▲ +202.8%
Range $3.50 – $5.00
Rating: Buy
Buy 71% · Hold 14% · Sell 14%

Get free alerts on CVRX and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.